Kohinoor Hospital which successfully removes 1.5 cm tumour from 47-year-oldman’s eye via nose

IMT News Desk
IMT News Desk
· 3 min read

~Swelling of the face and redness around the eye were the visible symptoms in this patient~
~A minimally invasive technique- transnasal endoscopic orbital surgery was performed for the first time in Kohinoor Hospital~
~A lack of timely treatment could have led to vision loss ~

Mumbai: A team led by Dr Sanjay Helale, ENT specialist and HOD at Kohinoor Hospital, successfully operated a 47-year-old man with an eye tumour by performing a minimally invasive procedure through nose. The patient’s vision has been restored, and he is back to his daily routine.

47-year-old Ramchandra Malkar, a resident of Mumbra suddenly encountered swelling of the face, and redness around the eye. Later, it was revealed that there is a tumour present in his left eye which was benign. A non-cancerous (benign) tumour of the eye can be described as a growth that does no spread (metastasize) to the other parts of the body, and also the non-cancerous tumours are not life-threatening. However, the patient was referred to Kohinoor Hospital, wherein Dr Sanjay Helale gave him a new lease of life.  

Dr Sanjay Helale, ENT specialist and HOD at Kohinoor Hospital, said, “The patient presented with left eye bulging out (it occurs when one or both eyes protrude from the eye sockets due to swelling of the muscles, fat, and tissue behind the eye), and congestion, over a month. After opting for an MRI, his vision and eye movements were normal. But, a 1.5 cm tumour was detected in the left eye, which could have caused vision impairment or permanent loss of vision. The tumours of the eye which are located of the nose side can be access through the nose. Thus, for the first time at Kohinoor Hospital, with the help of a minimally invasive technique, the tumour was removed via nose by performing a transnasal endoscopic orbital surgery. We secured the muscles of eyeball movement transconjunctivally after which anaesthesia was given.”

He added, “After performing the surgery for 2 hours, his eyeball has restored back to its position in the ball socket, and there is no threat to his vision. Moreover, the patient was discharged on the 3rd day of the surgery. Recently, nasal corridor has been approved for the brain and eye ball corridors without doing external scan. The endoscopic vision gives a cleaner vision and precision. Hence, one can explore this possibility with the treating doctor. Sometimes, the combined approach that is endoscopic and external, gives a better outcome than only the external alone.”

Patient Ramchandra Malkar said, “My life turned upside down, after I noticed that my face had swollen, and eyes had turned red. As a result, I couldn’t concentrate on my work. I was deeply saddened, and devastated, after doctor broke the news about the notorious tumour. But I believe that one should not lose hope no matter how hard the life is. Finally, my prayers were heard, and doctors at Kohinoor Hospital helped me get rid of the unpleasant tumour. I am thankful to the doctors who save my eye as I can do all my activities without any difficulties now.”  

 

Read Next

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet
News
April 16, 2026

‘One Nation, One Emergency Helpline’ Proposal for Stroke Care Gains Momentum at FICCI Meet

India’s stroke crisis demands urgent action, and the Indian Stroke Association (ISA) is leading the charge with a bold proposal for a unified national helpline. The ISA presented a comprehensive plan to strengthen stroke care delivery at a FICCI-hosted meeting attended by policymakers, healthcare leaders, and clinical experts. The plenary session, “Strengthening Stroke Care Delivery,” […]
Article by: IMT News Desk
Ivory raises fresh capital to strengthen deep tech offerings
News
April 16, 2026

Ivory raises fresh capital to strengthen deep tech offerings

Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical and IP capabilities. The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched […]
Article by: IMT News Desk
Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition
News
April 16, 2026

Rubicon Research Enters Indian CNS Formulations Market with Strategic Acquisition

Rubicon Research Limited today announced the acquisition of an 85% equity ownership in Arinna Lifesciences Limited from its current shareholders. With a portfolio of over 60 brands in chronic therapies, Arinna is one of the few domestic formulation companies principally focused on drugs treating conditions of the central nervous system (“CNS”) with more than 4,000 […]
Article by: IMT News Desk
MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide
News
April 16, 2026

MSN Laboratories Launches ‘SEMABEST, the First Integrated Made-in-India Semaglutide

MSN Laboratories has launched SEMABEST, its semaglutide brand, in the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO). SEMABEST is priced at nearly 50% lower than the innovator drug, significantly improving affordability and patient access. The therapy is available as a pre-filled pen for subcutaneous administration. In this evolving landscape, SEMABEST […]
Article by: IMT News Desk